Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

enue to be between $520 million and $550 million
  • Reported (GAAP) diluted earnings per share to be between $2.22 and $2.32
  • Adjusted diluted earnings per share to be between $4.55 and $4.65

  • The company's 2011 guidance is based on certain assumptions including:

  • Adjusted gross margin of between 69% and 71%
  • Adjusted effective tax rate of approximately 28%
  • Weighted average number of common shares outstanding of 123 million shares for the year ended December 31, 2011; and
  • No generic competition for Voltaren Gel in 2011

  • Selected Operating HighlightsOpana® ER Complete ResponseOn June 23, 2011, Endo Pharmaceuticals announced that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of Opana ER has been accepted.  The new formulation was developed in partnership with Grunenthal GmbH and is designed to provide some resistance to certain types of product manipulation.  FDA has set a Prescription Drug User Fee Act (PDUFA) date of Dec. 13, 2011.

    Completion of Acquisition of American Medical SystemsOn June 17, 2011, Endo Pharmaceuticals acquired American Medical Systems, Inc. (AMS), for approximately $2.9 billion. AMS brings Endo scale in its device and services business segment, and the combination of AMS with Endo's existing platform will provide additional cost-effective solutions across the entire urology spectrum.  It is expected that the combined company will deliver more comprehensive healthcare solutions across its diversified business in branded pharmaceuticals, generics, and devices and services in key therapeutic areas including pain and urology.

    Pricing of Private Offering of Senior Notes and 2011 Credit FacilityOn June 3, 2011, Endo Pharmaceuticals announced that it priced $500 million aggregate prin
    '/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Nov. 26, 2014   Royal Philips ... announced expanded availability of its portfolio of ... wDR, MobileDiagnost Opta[i] , ProGrade and PrimaryDiagnost[ii]. With ... available in the U.S., and availability of all ... offers Philips, customers innovative solutions designed to meet ...
    (Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
    (Date:11/26/2014)... Nov. 26, 2014 Scott Steiger lives in ... the world. As an engineer for the past 20 years, he,s ... the military service. He,s been to six of the seven continents. ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... he has a pretty good idea of what,s required. ...
    Breaking Medicine Technology:Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2
    ... announces that a new market research report is ... Drug Discovery in Emerging Markets ... markets have represented important growth opportunities for the ... the extent to which this has been accompanied ...
    ... Calif., Jan. 11, 2011 STAAR Surgical Company (Nasdaq: ... marketer of minimally invasive ophthalmic products, today announced that ... 31, 2010 to exceed $14.2 million. Revenues for the ... over 2009 revenues, driven by an increase of approximately ...
    Cached Medicine Technology:Reportlinker Adds Innovative Drug Discovery in Emerging Markets 2Reportlinker Adds Innovative Drug Discovery in Emerging Markets 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4
    (Date:11/27/2014)... November 28, 2014 The American Society for ... social media campaign in honor of World AIDS Day 2014. ... tested. Find a cure.” icon and infographic designed to generate ... getting tested for HIV. , ASCP has asked members to ... “Give a minute. Get Tested. Find a cure.” icon and ...
    (Date:11/27/2014)... 2014 Cambrionix Ltd today announced that it ... a ranking of the 50 fastest-growing technology companies in the ... the last five years. Cambrionix Ltd grew 2989 percent ... in the region of Cambridgeshire and East and first in ... “This award is recognition of the hard work put in ...
    (Date:11/27/2014)... 27, 2014 Nearly 1,100 Risperdal ... in a consolidated litigation now underway in Pennsylvania ... Documents recently updated in the Philadelphia Court of ... state proceeding, all of which involve a drug ... psychiatric conditions. Many of the cases in this ...
    (Date:11/27/2014)... 27, 2014 In order to enable people ... Fla., designed an easy way to avoid touching a toilet ... then created a prototype of the patent-pending Toilet Tamer, a ... toilet seat and/or lid in a more sanitary manner. It ... of germs. Overall, it promotes good hygiene and peace of ...
    (Date:11/27/2014)... Two international trainers and lecturers on ... help one person with significant needs but limited means ... Dr. Mamaly Reshad of the Anacapa Dental Art Institute ... website devoted to helping dentist learn about using All-on-4™ ... be devoted to helping a patient who has damaged ...
    Breaking Medicine News(10 mins):Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5
    ... anything but. Faced with health problems, financial issues and ... 65 years and older suffer from depression. While research ... problem, another group - centenarians - has been left largely ... hasn,t been studied thoroughly in this group," said Adam Davey, ...
    ... the new iPhone yet? Do you like changing jobs now ... on holiday to different places every year? Then maybe your ... developed. Both of them are centres in the brain. The ... in the striatum, whereas the hippocampus is responsible for specific ...
    ... facility located in Palm Springs, California has recently completed work on ... décor of the facility, but the overall recovery experience as well. ... ... -- The remodeling project, which took nearly a year and half ...
    ... to cut fat, salt a quick fix without losing taste, ... can eat healthier this holiday season by altering recipes and ... Extension Service. , Holiday cooks can reduce the sugar, ... a noticeable difference in taste, nutrition specialist Mary Bielamowicz said ...
    ... parents and schools need to work together to stop ... News) -- Behavior that was once dismissed as "kids ... as mounting research shows the negative effects on both ... and even kids themselves are coming up with new ...
    ... Corporation,(Nasdaq: HSKA ) today announced it will ... Annual Biotech and Specialty Pharma Conference on,December 2, 2008 ... New York, NY.,The presentation is scheduled to begin at ... be available via live webcast and for two weeks,following ...
    Cached Medicine News:Health News:Bittersweet milestones 2Health News:'Wiring' in the brain influences personality 2Health News:California Drug Rehab Facility Completes Comprehensive Remodeling Project 2Health News:California Drug Rehab Facility Completes Comprehensive Remodeling Project 3Health News:Substitutions Make Holiday Fare Healthier 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: